Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.47

€0.47

-7.840%
-0.04
-7.840%
-
 
05.06.25 / Stuttgart Stock Exchange WKN: A3DTUQ / Name: Vidac Pharma Holding Plc / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...

Vidac Pharma Holding Plc Stock

Heavy losses for Vidac Pharma Holding Plc today as the stock fell by -€0.040 (-7.840%).
So far the community has only identified positive things for Vidac Pharma Holding Plc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Vidac Pharma Holding Plc in the next few years

Pros
?
B****
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

U.S. grants broader patent to Vidac Pharma’s oncology drug candidates, adding range of new indications including prostate and pancreatic cancer
U.S. grants broader patent to Vidac Pharma’s oncology drug candidates, adding range of new indications including prostate and pancreatic cancer

-          U.S. patent office widens patent to include broad range of new cancer indications including prostate, pancreatic, lung, cervical and colon cancer

-          Vidac on track to meet